Drug Free Solution Inc
Drug Free Solution Inc provides healthcare services and equipment, primarily operating in the biotechnology segment of the healthcare industry.
Business. Drug Free Solution Inc (DSOL.PK) is a healthcare services and equipment company engaged in biotechnology activities. The firm operates within the healthcare facilities and services industry, generating revenue through service-based models. Headquarters location and specific operating segments are not disclosed in the available data. The company is listed on the OTC market under the ticker DSOL.PK.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Drug Free Solution Inc (DSOL.PK) is a healthcare services and equipment company engaged in biotechnology activities. The firm operates within the healthcare facilities and services industry, generating revenue through service-based models. Headquarters location and specific operating segments are not disclosed in the available data. The company is listed on the OTC market under the ticker DSOL.PK.
Drug Free Solution Inc has a capital structure characterized by a total equity of $20,030,000 and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The company's liquidity position is assessed as low, with an operating cash flow of -$625,330,000, indicating significant cash outflows from operations. This is further exacerbated by a negative return on equity of -0.8597, suggesting poor capital efficiency and profitability.
Profitability metrics show that the company is currently unprofitable, with an operating income and net income of -$17,220,000. These figures are below the industry median for profitability metrics, indicating that the company is underperforming relative to its peers in the Healthcare Facilities & Services industry.
The company's revenue concentration and geographic exposure are not explicitly detailed in the available data, but the absence of disclosed segments suggests a lack of diversification in its business operations. This could pose a risk if the company's primary market or product line experiences a downturn.
The company's growth trajectory is uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. However, the significant negative operating cash flow and net loss suggest that the company is not currently generating positive returns or experiencing growth. The absence of capital expenditures beyond -$4,870,000 also indicates limited investment in future growth.
Risk factors for Drug Free Solution Inc include a low liquidity position and the potential for dilution, although the risk of dilution is currently assessed as low. The company has no immediate filing-based liquidity or dilution flags, but the negative operating cash flow and net loss could signal underlying financial stress. No adjustments have been applied to the valuation metrics, indicating that the reported figures are unadjusted.
Recent events and filings do not show any significant developments that would impact the company's financial position or strategic direction. The absence of disclosed events or transcripts suggests a lack of recent material activity or communication from the company.
- Drug Free Solution Inc is currently unprofitable with a net loss of $17,220,000 and a negative return on equity of -0.8597.
- The company has no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative capital structure.
- Operating cash flow is significantly negative at -$625,330,000, signaling liquidity challenges.
- The company's growth trajectory is unclear, with no specific numeric deltas provided for the current or next fiscal year.
- The risk of dilution is currently assessed as low, but the company's financial performance could change this outlook.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Drug Free Solution Inc Market data — financials · 2026-05-27